Publication Date:
2016-02-04
Description:
A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome Leukemia 30, 268 (February 2016). doi:10.1038/leu.2015.244 Authors: N Daver, H Kantarjian, F Ravandi, E Estey, X Wang, G Garcia-Manero, E Jabbour, M Konopleva, S O'Brien, S Verstovsek, T Kadia, C Dinardo, S Pierce, X Huang, N Pemmaraju, M Diaz-Pines-Mateo, J Cortes & G Borthakur
Print ISSN:
0887-6924
Electronic ISSN:
1476-5551
Topics:
Medicine
Permalink